Brimonidine Tartrate Ophthalmic Solution 0.2% is a prescription eye medication that may be prescribed by veterinarians to help lower elevated intraocular pressure (IOP). Brimonidine is classified as a relatively selective alpha-2 adrenergic receptor agonist.
The medication works by decreasing the production of aqueous humor within the eye while also increasing uveoscleral outflow. Together, these actions help lower pressure within the eye.
When prescribed for an animal, Brimonidine should be administered exactly according to the veterinarian's directions. Do not change the dose or frequency without consulting the prescribing veterinarian.
Brimonidine is a relatively selective alpha-2 adrenergic receptor agonist.
It lowers intraocular pressure through two complementary actions: reducing the production of aqueous humor within the eye and increasing uveoscleral outflow. This dual mechanism helps decrease pressure within the eye.
Brimonidine Tartrate Ophthalmic Solution 0.2% may be prescribed by a veterinarian for animals requiring management of elevated intraocular pressure.
Use only for the animal and condition for which it was prescribed.
Active Ingredients:
Brimonidine Tartrate 0.2% (2 mg/mL)
Inactive Ingredients:
For topical ophthalmic use.
Administer Brimonidine Tartrate Ophthalmic Solution exactly as prescribed by your veterinarian.
Wash hands before administration. Avoid touching the dropper tip to the eye, eyelids, fingers, or other surfaces to help prevent contamination.
If more than one topical ophthalmic medication has been prescribed, administer the products at least 5 minutes apart, unless otherwise directed by your veterinarian.
Replace the cap securely after each use.
Weight / Dosage
Dosage is determined by the prescribing veterinarian based on the animal's individual needs and response to therapy.
Follow the prescription label exactly.
Brimonidine may cause local or systemic adverse effects. Possible reactions may include:
Contact your veterinarian if side effects are persistent, severe, or concerning.
Use only under veterinary supervision.
Avoid contaminating the dispensing tip. Always replace the cap after administration.
If another ophthalmic medication is being administered, separate applications by at least 5 minutes unless your veterinarian provides different instructions.
Do not discontinue or change the prescribed dosing schedule without consulting your veterinarian.
Store at controlled room temperature. Current brimonidine 0.2% ophthalmic labels specify storage within approximately 59°F to 77°F (15°C to 25°C) or 68°F to 77°F (20°C to 25°C) depending on manufacturer. Keep the bottle tightly closed and protected from contamination.
Disposal
Dispose of unused or expired medication according to applicable local requirements. Do not use after the expiration date printed on the packaging.